While this was initially interpreted as ERRγ being a favorable prognostic indicator, subsequent studies have found ERRγ expression to be associated with positive lymph node status [46] and an increased risk of recurrence in ER+ breast cancer [14,38]. The gene discussed is ESRRG; the disease is breast cancer.